CHIMA ASIKAIWE: Open Payments
NPI 1992003669 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 20 payments from 11 companies in 2025. Trend: 2023 $621 · 2024 $590 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Corium, LLC | 3 | $65 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: Deep TMS System, CAPLYTA, Azstarys, Qelbree, SPRAVATO, FANAPT, Auvelity, UZEDY.
Industry payments across TX — which companies pay providers there.
